Michael P Rutz, the President of Sterigenics of $SHC, sold 126,611 shares of the company on 08-22-2025 for an estimated $2,074,305. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.0% of their shares of this class of stock. Following this trade, they now own 450,204 shares of this class of $SHC stock.
$SHC Insider Trading Activity
$SHC insiders have traded $SHC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SHC stock by insiders over the last 6 months:
- MICHAEL P RUTZ (President of Sterigenics) sold 126,611 shares for an estimated $2,074,305
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SHC Hedge Fund Activity
We have seen 149 institutional investors add shares of $SHC stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TPG GP A, LLC removed 6,786,110 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $75,461,543
- SCULPTOR CAPITAL LP added 2,462,489 shares (+27.2%) to their portfolio in Q2 2025, for an estimated $27,382,877
- ARROWMARK COLORADO HOLDINGS LLC removed 1,867,829 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,770,258
- POINT72 (DIFC) LTD added 1,136,326 shares (+192.6%) to their portfolio in Q2 2025, for an estimated $12,635,945
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,101,604 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,249,836
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,007,963 shares (+12.5%) to their portfolio in Q2 2025, for an estimated $11,208,548
- KHROM CAPITAL MANAGEMENT LLC added 988,801 shares (+174.1%) to their portfolio in Q2 2025, for an estimated $10,995,467
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SHC Analyst Ratings
Wall Street analysts have issued reports on $SHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/24/2025
- Goldman Sachs issued a "Buy" rating on 05/05/2025
To track analyst ratings and price targets for $SHC, check out Quiver Quantitative's $SHC forecast page.
$SHC Price Targets
Multiple analysts have issued price targets for $SHC recently. We have seen 3 analysts offer price targets for $SHC in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $13.0 on 06/24/2025
- Matthew Sykes from Goldman Sachs set a target price of $17.0 on 05/05/2025
- Jason Bednar from Piper Sandler set a target price of $13.0 on 04/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
